SMi reports: Alan Franklin, CEO, ForwardVue Pharma will be presenting at the Ophthalmic Drugs conference The 4th Annual Ophthalmic Drugs Conference taking place on the
SMi are delighted to have interviewed Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals regarding his thoughts and experiences within the ophthalmology space.
With the event now Just 1 week away, I wanted to remind you that there is still time to secure your place at Europe's Leading Ophthalmic Conference; SMi's Ophthalmic Drugs, taking place on November
Featuring an exceptional line-up of keynote speakers from industry leading organisations, Europe's leading conference on Ophthalmic Drugs arrives at the perfect time to discuss the latest approache
Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at almost $5 bi
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio